A novel broad-spectrum anti-viral
Dr. Todd Rider invented DRACOs (Double-stranded RNA Activated Caspase Oligomerizers) at MIT. DRACOs are novel broad-spectrum antiviral drugs that have the potential to revolutionize the treatment and prevention of virtually ALL viral diseases. So far, DRACOs have successfully treated 18 viruses in laboratory tests. DRACOs have proved effective against rhinovirus (the common cold), H1N1 influenza (flu), dengue hemorrhagic fever virus, and more. (This is a non-profit crowdfunding campaign.)
The basic mechanism is that double-stranded RNA only occurs within virally-infected cells, and it is only this type of RNA which activates the DRACO to trigger cell-death.